GlassScriptPhysician profile
Bradford March
NPI 1396032033
$6,025.64
in general payments reported to CMS, 2019-2025
9 companies · $1,103 in 2025
The $1,103 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $403 · 2020: $515 · 2021: $2,023 · 2022: $341 · 2023: $714 · 2024: $925 · 2025: $1,103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,742.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,631.60 | 2020-2025 | General - Embolics, Embold Fibered, Cryoablation Needles |
| Penumbra, INC. | $1,991.85 | 2019-2022 | |
| Stryker Corporation | $324.42 | 2021-2022 | |
| Siemens Medical Solutions USA, INC. | $278.36 | 2023-2025 | Microthermx Microwave Ablation System, Embozene |
| Biocompatibles, INC. | $273.26 | 2019 | |
| Ethicon US, LLC | $199.90 | 2020-2021 | |
| Angiodynamics, INC. | $178.14 | 2021-2023 | Alphavac |
| Sirtex Medical INC | $132.53 | 2024-2025 | Lava Les (Liquid Embolic System), Sir-Spheres Microspheres |
| Terumo Medical Corporation | $15.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradford March listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.